Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 11 Colorectal Neoplasms 10 Colonic Neoplasms 4 Pancreatic Neoplasms 2 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Metastasis Colon Cancer 1 Carcinoma, Neuroendocrine 1

Interventions

Carboplatin 7 Trastuzumab 6 Docetaxel 5 pembrolizumab 4 Paclitaxel 4 Oxaliplatin 4 Fluorouracil 4 Cytarabine 4 Cyclophosphamide 4 Azacitidine 4 pertuzumab 3 Radiotherapy 3 Observation 3 Neoadjuvant Therapy 3 Epirubicin 3 Endoscopy 3 Cisplatin 3 Chemoradiotherapy 3 Capecitabine 3 venetoclax 2 toripalimab 2 sargramostim 2 olaparib 2 durvalumab 2 cc-486 2 Tretinoin 2 Surgical Procedures, Operative 2 Standard of Care 2 Pemetrexed 2 Monatide (IMS 3015) 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × FOLFOXIRI protocol × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡